Technical Analysis for TEVA - Teva Pharmaceutical Industries

Grade Last Price % Change Price Change
D 8.73 -0.80% -0.07
TEVA closed down 0.8 percent on Wednesday, March 22, 2023, on 81 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -0.80%
Lower Bollinger Band Walk Weakness -0.80%
Gapped Up Strength -0.80%
Oversold Stochastic Weakness -0.80%
Slingshot Bearish Bearish Swing Setup 2.34%
Bullish Engulfing Bullish 2.34%
Pocket Pivot Bullish Swing Setup 2.34%
Lower Bollinger Band Walk Weakness 2.34%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 9 hours ago
10 DMA Support about 10 hours ago
Reversed from Up about 10 hours ago
Gap Up Closed about 10 hours ago
60 Minute Opening Range Breakdown about 13 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Teva Pharmaceutical Industries Description

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. The company's principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Azilect for the treatment of Parkinson's disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, and musculoskeletal conditions; ProAir for the treatment of bronchial spasms; Qvar for long-term control of chronic bronchial asthma; and Qnasl Nasal Aerosol for seasonal nasal and year-round nasal allergy symptoms. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Synribo for chronic myeloid leukemia; Plan B One-Step for emergency oral contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapies for menopause/perimenopause; Enjuvia for vasomotor symptoms associated with menopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company distributes third party products. It has collaborative agreements with Lonza Group Ltd. and OncoGenex Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Drugs Pain Medication Pharmaceutical Products Lymphoma Parkinson's Disease Opioids Spas Leukemia Multiple Sclerosis Allergy Asthma MRI Active Pharmaceutical Ingredients Hormones Cholesterol Pharmaceutical Industries Fertility Sleep Apnea Chronic Lymphocytic Leukemia Lymphocytic Leukemia Red Blood Cell Treatment Of Parkinson's Disease Obstructive Sleep Apnea Blood Cells Generic Pharmaceutical Infertility Narcolepsy Chemical Entities Xone Birth Control Immunosuppressants Hot Flash Teva Pharmaceutical Industries Urinary Incontinence Chronic Myeloid Leukemia Fentanyl Muscle Spasm Oncogene Party Products Treatment Of Chronic Lymphocytic Leukemia Bronchial Asthma Contraception Menopause Muscle Relaxants Nasal Allergy Spasms

Is TEVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 11.445
52 Week Low 6.78
Average Volume 8,533,273
200-Day Moving Average 9.06
50-Day Moving Average 10.02
20-Day Moving Average 9.33
10-Day Moving Average 8.79
Average True Range 0.30
RSI 35.48
ADX 30.45
+DI 18.88
-DI 29.19
Chandelier Exit (Long, 3 ATRs) 9.25
Chandelier Exit (Short, 3 ATRs) 9.16
Upper Bollinger Bands 10.53
Lower Bollinger Band 8.14
Percent B (%b) 0.25
BandWidth 25.52
MACD Line -0.40
MACD Signal Line -0.34
MACD Histogram -0.0601
Fundamentals Value
Market Cap 9.57 Billion
Num Shares 1.1 Billion
EPS 0.00
Price-to-Earnings (P/E) Ratio 2182.50
Price-to-Sales 0.64
Price-to-Book 1.11
PEG Ratio 1.25
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.14
Resistance 3 (R3) 9.18 9.09 9.07
Resistance 2 (R2) 9.09 8.99 9.07 9.04
Resistance 1 (R1) 8.91 8.92 8.87 8.87 9.02
Pivot Point 8.82 8.82 8.80 8.80 8.82
Support 1 (S1) 8.64 8.72 8.60 8.60 8.44
Support 2 (S2) 8.55 8.65 8.53 8.42
Support 3 (S3) 8.37 8.55 8.39
Support 4 (S4) 8.33